Advertisement

Topics

Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Company Profile

03:07 EDT 20th April 2018 | BioPortfolio


News Articles [1707 Associated News Articles listed on BioPortfolio]

Takeda and Seattle Genetics present full data for Adcetris in Hodgkin lymphoma

Tokyo’s Takeda Pharmaceutical and US-based Seattle Genetics presented positive data from the Phase…

Takeda reports positive Phase lll data of adcetris combination

Takeda Pharmaceutical Company and Seattle Genetics have reported positive results in a Phase lll clinical trial assessing adcetris (brentuximabvedotin) under...Read More... The post Takeda reports pos...

FDA accepts sBLA of Seattle Genetics’ ADCETRIS for Hodgkin lymphoma

The US Food and Drug Administration (FDA) has accepted filing of a supplemental biologics licence application (sBLA) by Seattle Genetics...Read More... The post FDA accepts sBLA of Seattle Genetics’...

PharmaMar lizensiert vollsynthetisch aus Meeressubstanzen gewonnene Payloads für Wirkstoff-Konjugate an Seattle Genetics

Madrid (ots/PRNewswire) - PharmaMar (MCE: PHM) hat heute die Unterzeichnung einer exklusiven Lizenzvereinbarung mit Seattle Genetics Inc. (SGEN: NASDAQ GS) bekanntgegeben, nach der Seattle Genetics...

Seattle Genetics to Acquire Cascadian Therapeutics for $614 Million, Adding Late-Stage Breast Cancer Program

att BOTHELL, Wash. & SEATTLE–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Cascadian Therapeutics, Inc. (Nasdaq:CASC) today announced the signing of a definitive merger agr...

Seattle Genetics Drug Scratches Out Win In Hodgkin Lymphoma

In a closely watched result, Adcentris, a cancer drug sold by the biotech firm Seattle Genetics and the Japanese drug giant Takeda, outperformed traditional chemotherapy in front-line Hodgkin lymphoma...

Seattle Genetics Acquires Cascadian Therapeutics, Continuing a Strong ...

On January 31, two Seattle biotech companies, Seattle Genetics and Cascadian Therapeutics, announced a merger agreement under which Seattle Genetics will acquire Cascadian Therapeutics for $614 millio...

Seattle Genetics To Acquire Cascadian Therapeutics

NewsThe acquisition will enhance Seattle Genetics’ portfolio of solid tumor programs with potential rapid registration pathways and provides global rights to a pivotal Phase 2 program in development...

PubMed Articles [1006 Associated PubMed Articles listed on BioPortfolio]

10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016.

The aim of this study was to critically assess the evaluation and categorization process for nephrogenic systemic fibrosis (NSF) based on reports received by Bayer from 2006 to 2016.

Editorial: In Good Company.

Corrigendum for Takeda K et al. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 2007;137(Suppl):791S-3S.

Bacteria and fungi in day-old turkeys vary among companies, collection periods, and breeder flocks.

Microbial colonization of the intestinal tract of commercial poultry is highly variable, likely due to the fact that poults and chicks are hatched and raised without exposure to adult birds and their ...

Crimean Thornapple Depicted by Liebig's Extract of Meat Company.

Clinical Trials [700 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

Impact of Non-Commercialism Policy in Seattle Schools

This pilot study on the impact of a non-commercialism policy in Seattle schools will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on a...

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Impact of Non-Commercialism Policy in Seattle Schools

This is a 3-year pilot study funded by National Institute of Health will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on and adopted b...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Companies [3196 Associated Companies listed on BioPortfolio]

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Takeda San Francisco, Inc.

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antib...

Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc.

Takeda Pharmaceutical Company Limited and Seattle Genetics, Inc.

Envoy Therapeutics Inc. and Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global lea...

More Information about "Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc." on BioPortfolio

We have published hundreds of Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. news stories on BioPortfolio along with dozens of Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Clinical Trials and PubMed Articles about Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Companies in our database. You can also find out about relevant Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record